A Rutgers research team has completed the first evaluation of a rapid COVID-19 test given emergency approval by the FDA. The test, which delivers results in as little as 45 minutes, will be available next week.
Conventional coronavirus tests are sent to a centralized lab and results can take from one to five days.
Rapid testing will be a game-changer in the fight against COVID-19, speeding crucial medical decisions, including how to triage patients, when to isolate and how to treat. Additionally, as the world continues to manage COVID-19 in the coming years, the test could potentially be used in doctor’s offices, clinics and even mobile units to help detect small outbreaks of the disease before large-scale outbreaks reoccur.
David Alland, director of the Public Health Institute at Rutgers New Jersey Medical School, led the research team that assessed the test, which was developed by CEPHEID, a U.S. molecular diagnostics company.